{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:14:55Z","timestamp":1790194495110,"version":"4.1.0"},"reference-count":85,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cutaneous melanoma accounts for more than 70% of all skin cancer deaths. Follow-up surveillance is an integral part of melanoma patient care, to facilitate early detection of recurrences and subsequent primary melanomas. The purpose of this scoping review is to provide an overview of recently published melanoma surveillance guidelines from regional and national melanoma working groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search for relevant studies in MEDLINE and Embase was conducted in September 2022 and was limited to publications from 2010 or later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1047 articles were retrieved, and after abstract and full text review, 26 articles from 19 different organizations met inclusion criteria. Life-long annual skin surveillance with a physician was recommended by 53% (9\/17) of guidelines. Routine laboratory investigations were recommended by 7\/19 guidelines. Regional lymph node ultrasound was recommended by 9\/16 guidelines, most often in stage IB or higher, and was optional in 7\/16 for patients who met specific criteria. Surveillance with PET-CT or CT and MRI was recommended by 15 and 11 guidelines, respectively, most commonly in stage IIC or higher, with a variable frequency and total duration. Five out of 9 guidelines indicated a preference for skin surveillance to be completed with a dermatologist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Guidelines were highly variable for many aspects of melanoma surveillance, which may be partly attributed to regional differences in healthcare workforce distribution and availability of imaging technologies. Further high-level studies are recommended to provide more evidence on the most effective clinical and imaging follow-up surveillance protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/12034754231188434","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T09:03:09Z","timestamp":1690275789000},"page":"516-525","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":31,"title":["Surveillance After a Previous Cutaneous Melanoma Diagnosis: A Scoping Review of Melanoma Follow-Up Guidelines"],"prefix":"10.1177","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0994-1603","authenticated-orcid":false,"given":"Leah","family":"Johnston","sequence":"first","affiliation":[{"name":"Cumming School of Medicine, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Starkey","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-9413","authenticated-orcid":false,"given":"Ilya","family":"Mukovozov","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Robertson","sequence":"additional","affiliation":[{"name":"Division of Dermatology, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Petrella","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Odette Cancer Centre, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Alhusayen","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Division of Dermatology, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"bibr1-12034754231188434","unstructured":"National Cancer Institute. Melanoma of the Skin-Cancer Stat Facts. Accessed December 19, 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"},{"key":"bibr2-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.109"},{"key":"bibr3-12034754231188434","doi-asserted-by":"crossref","unstructured":"Dzwierzynski WW., Surg CP. Melanoma risk factors and prevention. 2021;48(4):543-550.","DOI":"10.1016\/j.cps.2021.05.001"},{"key":"bibr4-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16341"},{"key":"bibr5-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.074"},{"key":"bibr6-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2018.1489246"},{"key":"bibr7-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01206-X"},{"key":"bibr8-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2019.09.011"},{"key":"bibr9-12034754231188434","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"bibr10-12034754231188434","unstructured":"Barbour A, Millward M, Morton R, Saw R, Cancer Council Australia Melanoma Working Guidelines Party2018. Guidelines: investigations and follow-up for melanoma patients. clinical practice guidelines for the diagnosis and management of melanoma. Accessed September 18, 2022 Melanoma Institute Australia. https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Investigations_and_Follow-up_for_Melanoma_Patients"},{"key":"bibr11-12034754231188434","unstructured":"Morton R, Barbour A, Bell C, Mar V, Smithers M, Cancer Council Australia Melanoma Working Guidelines Party. Clinical question: What investigations should be performed following a diagnosis of primary cutaneous melanoma for asymptomatic stage I and stage II patients? Melanoma Institute Australia. Updated May 25, 2018. Accessed September 18, 2022. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:What_investigations_should_be_performed_following_a_diagnosis_of_primary_cutaneous_melanoma_for_asymptomatic_Stage_I_and_II_patients%3F"},{"key":"bibr12-12034754231188434","unstructured":"Saw R, Menzies A, McArthur G, Spillane J, Haydon A, Cancer Council Australia Melanoma Working Guidelines Party. Clinical question: What investigations should be performed when in-transit and\/or regional node disease (stage III melanoma) is diagnosed? Melanoma Institute Australia. Updated May 25, 2018. Accessed September 18, 2022. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:What_investigations_should_be_performed_when_in_transit_and\/or_regional_node_disease_(Stage_III_melanoma)_is_diagnosed%3F"},{"key":"bibr13-12034754231188434","unstructured":"Millward M, Menzies A, Atkinson V, Brown M, Haydon A, Cancer Council Australia Melanoma Working Guidelines Party. Clinical question: What investigations should be performed when stage IV melanoma is diagnosed? Melanoma Institute Australia. Updated May 25, 2018. Accessed September 18, 2022. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:What_investigations_should_be_performed_when_Stage_IV_melanoma_is_diagnosed%3F"},{"key":"bibr14-12034754231188434","unstructured":"Barbour A, Guminski A, Liu W, Menzies S, Morton R, Cancer Council Australia Melanoma Working Guidelines Party2018. Clinical question: follow up after initial definitive treatment for each stage of melanoma. Accessed September 18, 2022 Melanoma Institute Australia. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:How_should_patients_at_each_stage_of_melanoma_be_followed_after_initial_definitive_treatment%3F"},{"key":"bibr15-12034754231188434","unstructured":"Barbour A, Guminski A, Liu W, Menzies S, Morton R, Cancer Council Australia Melanoma Working Guidelines Party2019. Clinical question: ideal settings, duration and frequency of follow-up for patients with melanoma. Accessed September 18, 2022 Melanoma Institute Australia. https:\/\/wiki.cancer.org.au\/australia\/Clinical_question:What_is_the_ideal_setting,_duration_and_frequency_of_follow-up_for_melanoma_patients%3F"},{"key":"bibr16-12034754231188434","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-02-20-5238"},{"key":"bibr17-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20164715"},{"key":"bibr18-12034754231188434","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28030189"},{"issue":"1","key":"bibr19-12034754231188434","first-page":"17","volume":"139","author":"Herceg D.","year":"2016","journal-title":"Lijec Vjesn"},{"issue":"1","key":"bibr20-12034754231188434","first-page":"22","volume":"138","author":"Herceg D.","year":"2016","journal-title":"Lijec Vjesn"},{"key":"bibr21-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.03.008"},{"key":"bibr22-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz411"},{"key":"bibr23-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14064"},{"issue":"6","key":"bibr24-12034754231188434","first-page":"1","volume":"11","author":"Pflugfelder A.","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"bibr25-12034754231188434","first-page":"633","volume":"149","author":"Moscarella E.","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"issue":"1528","key":"bibr26-12034754231188434","first-page":"79","volume":"134","author":"Francis V.","year":"2021","journal-title":"N Z Med J"},{"key":"bibr27-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-014-0151-y"},{"key":"bibr28-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02822-x"},{"issue":"4","key":"bibr29-12034754231188434","first-page":"129","volume":"101","author":"Mangas C.","year":"2010","journal-title":"Consensus statement of the Network of Catalan and Balearic Melanoma Centers] [published correction appears in Actas Dermosifiliogr"},{"key":"bibr30-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02539-9"},{"key":"bibr31-12034754231188434","volume":"146","author":"Dummer R.","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"bibr32-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2010.07.006"},{"issue":"351","key":"bibr33-12034754231188434","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h3708","volume":"351","author":"Macbeth F","year":"2015","journal-title":"BMJ"},{"key":"bibr34-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.055"},{"issue":"4","key":"bibr35-12034754231188434","first-page":"367","volume":"17","author":"Swetter SM.","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"bibr36-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799"},{"key":"bibr37-12034754231188434","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21409"},{"key":"bibr38-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.068"},{"key":"bibr39-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1177\/1203475419856611"},{"key":"bibr40-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6476-5"},{"key":"bibr41-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2013.856272"},{"key":"bibr42-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5642-0"},{"key":"bibr43-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2016.12.038"},{"key":"bibr44-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-5768-8"},{"key":"bibr45-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibaa003"},{"key":"bibr46-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.772"},{"key":"bibr47-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.01.007"},{"key":"bibr48-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.02.1229"},{"key":"bibr49-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000344"},{"key":"bibr50-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2021.4054"},{"key":"bibr51-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000332"},{"key":"bibr52-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-010-0859-8"},{"key":"bibr53-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-018-0537-6"},{"key":"bibr54-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.1134"},{"key":"bibr55-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa088"},{"key":"bibr56-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33307"},{"key":"bibr57-12034754231188434","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2598"},{"key":"bibr58-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15194"},{"key":"bibr59-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000395"},{"key":"bibr60-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09961.x"},{"key":"bibr61-12034754231188434","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9520"},{"key":"bibr62-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.2"},{"key":"bibr63-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15024"},{"key":"bibr64-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11123.x"},{"key":"bibr65-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.06.059"},{"key":"bibr66-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5263-7"},{"key":"bibr67-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605638"},{"key":"bibr68-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1586\/era.11.115"},{"key":"bibr69-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq455"},{"key":"bibr70-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.07.051"},{"key":"bibr71-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e328348dad3"},{"key":"bibr72-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11621"},{"key":"bibr73-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26214"},{"key":"bibr74-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000233"},{"key":"bibr75-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103044"},{"key":"bibr76-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy124"},{"issue":"6","key":"bibr77-12034754231188434","first-page":"255","volume":"7","author":"Vensby PH.","year":"2017","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"bibr78-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2016.1213879"},{"issue":"1","key":"bibr79-12034754231188434","first-page":"17","volume":"4","author":"Danielsen M.","year":"2013","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"bibr80-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.06.011"},{"key":"bibr81-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09270-3"},{"issue":"2","key":"bibr82-12034754231188434","first-page":"158","volume":"14","author":"Gebhardt C.","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"bibr83-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16212"},{"key":"bibr84-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-0963-x"},{"key":"bibr85-12034754231188434","doi-asserted-by":"publisher","DOI":"10.1002\/jso.25682"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754231188434","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754231188434","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754231188434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:49:58Z","timestamp":1777391398000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/12034754231188434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1177\/12034754231188434"],"URL":"https:\/\/doi.org\/10.1177\/12034754231188434","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]}}}